StockTipsArenaBeta

Blue Jet Healthcare Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹495.4-12.05 (-2.37%)
As of 21 Oct 2026

Avg 1-year target

All 5 long-term calls are BUY

₹70041.3% above today's price

Blue Jet Healthcare's average 1-year share price target is ₹700, the average of 2 advisors' latest targets. Targets range from ₹680 to ₹720.

Latest: Motilal Oswal ₹720 · 18 Aug 2026

5
5 BUY · 0 SELL, all horizons
2
with an active 1Y target
54%
7 of 13 closed calls hit
18
all horizons, open and closed
Watch BLUEJET for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

Blue Jet Healthcare target price by brokerage

Each advisor's latest 1-year target · 2 advisors · tap a row for the call

All tips (18)

BUYTarget₹720
MObyMotilal Oswal+45.3% to target
1 Year* · 10 mo left · 18 Aug 2026 · entry ₹589.95 · via ET Now (Live)P&L -16.0%
BUYTarget₹680
ISbyICICI Securities+37.3% to target
1 Year* · 10 mo left · 4 Aug 2026 · entry ₹582.05 · via Moneycontrol Broker ResearchP&L -14.9%
BUYTarget₹710
MObyMotilal Oswal+43.3% to target
1 Year* · 10 mo left · 3 Aug 2026 · entry ₹589.5 · via Institutional / Brokerage ResearchP&L -16.0%
BUYTarget₹770
MObyMotilal Oswal+55.4% to target
1 Year* · 2 wk left · 5 Nov 2025 · entry ₹606.65 · via Institutional / Brokerage ResearchP&L -18.3%
BUYTarget₹750
ISbyICICI Securities+51.4% to target
1 Year* · 2 wk left · 5 Nov 2025 · entry ₹606.65 · via Institutional / Brokerage ResearchP&L -18.3%
BUYTarget₹500
ISbyICICI SecuritiesTarget hit
1 Year* · 15 Feb 2026 · entry ₹366.95 · via Institutional / Brokerage Researchexit ₹500
BUYTarget₹500
MObyMotilal OswalTarget hit
1 Year* · 14 Feb 2026 · entry ₹366.95 · via Institutional / Brokerage Researchexit ₹500
BUYTarget₹965
MObyMotilal OswalTarget hit
1 Year* · 14 May 2025 · entry ₹770.15 · via Institutional / Brokerage Researchexit ₹965
BUYTarget₹600
ISbyICICI SecuritiesTarget hit
1 Year* · 8 Aug 2024 · entry ₹485.25 · via Institutional / Brokerage Researchexit ₹600
BUYTarget₹445
ISbyICICI SecuritiesTarget hit
1 Year* · 28 May 2024 · entry ₹372.65 · via Institutional / Brokerage Researchexit ₹445
BUYTarget₹1,100
MObyMotilal OswalExpired
1 Year* · 23 Jul 2025 · entry ₹816.7 · via Institutional / Brokerage Researchexit ₹576.5
BUYTarget₹537
ASbyAmit Shreeram GoelTarget hit
1–2 Weeks* · 12 Jun 2026 · entry ₹511.65 · via NDTV Profit (Live)exit ₹537
BUYTarget₹665
DMbyDeven Mehata, IDBI Capital Markets and SecuritiesStop-loss hit
1–2 Weeks* · 24 Aug 2026 · entry ₹609.35 · via CNBC Awaaz.exit ₹590
BUYTarget₹630
RSbyRajesh SatputeStop-loss hit
1–2 Weeks* · 7 Aug 2026 · entry ₹594.7 · via CNBC Awaaz.exit ₹590
BUYTarget₹630
PRbyPankaj RandadStop-loss hit
1–2 Weeks* · 7 Aug 2026 · entry ₹596.05 · via CNBC Awaaz.exit ₹590
BUYTarget₹625
MJbyManas JaiswalStop-loss hit
1–2 Weeks* · 24 Jul 2026 · entry ₹594.3 · via CNBC Awaaz.exit ₹579
BUYTarget₹620
SRbySahi ResearchExpired
1–2 Weeks* · 13 Aug 2026 · entry ₹592.5 · via Sahi Research Telegramexit ₹590
BUYTarget₹615
RBbyRakesh BansalTarget hit
Intraday* · 10 Jul 2026 · entry ₹608 · via Zee Business (Live)exit ₹615

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks